低疼痛反应者全膝关节置换术前高剂量地塞米松随机双盲试验
这项双中心随机双盲试验比较了术前静脉地塞米松1 mg kg-1与0.3 mg kg-1对160例低术前疼痛灾难化且未使用阿片类药物的全膝关节置换患者术后疼痛的影响。高剂量组仅48小时C反应蛋白较低,其他疼痛及恢复结局均无差异。
要点
- 低疼痛反应者TKA术前高剂量地塞米松未改善术后24小时行走疼痛。
- 高剂量组仅48小时C反应蛋白低于低剂量组,24小时无差异。
- 阿片类药物用量、恢复质量、住院时间及并发症两组均无差异。
核心结论
- 在低疼痛反应者中,TKA术前静脉地塞米松1 mg kg-1相比0.3 mg kg-1未改善早期术后疼痛或其他结局。
研究设计与样本
- 两中心、双盲、双臂随机对照试验,纳入160例计划行TKA且术前疼痛灾难化评分低、未使用阿片类药物的受试者,比较术前静脉地塞米松1 mg kg-1与0.3 mg kg-1。
- 所有受试者接受对乙酰氨基酚、环氧化酶-2抑制剂、局部麻醉药浸润镇痛及补救阿片类药物的多模式镇痛。
主要发现
- 共157例受试者纳入分析(80 vs 77)。
- 术后24小时行走时VAS>30 mm的发生率两组分别为56%与53%,相对风险=1.07,置信区间0.8-1.4,P=0.65。
- 其他疼痛结局、补救阿片类药物及止吐药使用、恢复质量-15评分、阿片类药物相关症状困扰量表、住院时间、再入院及并发症均无差异。
- C反应蛋白24小时两组相当(13 [6-25] mg L-1 vs 16 [9-38] mg L-1,P=0.07),48小时高剂量组较低(26 [9-52] mg L-1 vs 50 [30-72] mg L-1,P<0.01)。
临床怎么用
- 对于术前疼痛灾难化评分低且未使用阿片类药物的TKA患者,不应期望通过增加术前地塞米松剂量至1 mg kg-1来改善早期术后疼痛。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative pain after total knee arthroplasty (TKA) is a continuing problem despite optimised multimodal analgesia. Previous studies have shown preoperative glucocorticoids to reduce postoperative pain, but knowledge about specific doses and effects in specific patient groups is lacking. METHODS: A two-centre, double-blind, two-arm study comparing preoperative dexamethasone (1 mg kg-1vs 0.3 mg kg-1 i.v.) on postoperative pain in 160 planned TKA subjects with low preoperative pain catastrophising and no opioid use. Subjects received multimodal analgesia with paracetamol, cyclooxygenase-2 inhibitors, local anaesthetic infiltration analgesia, and rescue opioids. The primary outcome was percentage of subjects experiencing moderate to severe pain (visual analogue scale >30 mm) upon ambulation at 24 h. Secondary outcomes included pain scores, postoperative inflammation (C-reactive protein), opioid and antiemetics use, and 'Quality of Recovery-15' and 'Opioid-Related Symptom Distress Scale', length of stay, readmissions, and complications up to Day 90. RESULTS: A total of 157 subjects (80 vs 77) were included. No difference was found between groups in the incidence of subjects experiencing visual analogue scale >30 on ambulation 24 h after surgery (56% vs 53%, relative risk =1.07, confidence interval: 0.8-1.4, P=0.65). No differences in other pain outcomes or use of rescue opioids and antiemetics, in Quality of Recovery-15 and Opioid-Related Symptom Distress Scale, length of stay, readmissions, or complications. C-reactive protein values were comparable at 24 h (13 [6-25] mg L-1vs 16 [9-38] mg L-1, P = 0.07), but lower at 48 h (26 [9-52] mg L-1vs 50 [30-72] mg L-1, P<0.01) in the high-dose group. CONCLUSION: Use of 1 mg kg-1vs 0.3 mg kg-1 i.v. dexamethasone in low pain responders after TKA did not improve early postoperative pain or other outcomes in contrast to benefits in a high pain responder population. CLINICAL TRIAL REGISTRATION: NCT03758170 (first registration 29-11-2018).
引用
- Nielsen NI, Kehlet H, Gromov K, et al. High-dose dexamethasone in low pain responders undergoing total knee arthroplasty: a randomised double-blind trial. Br J Anaesth. 2022. PMID: 36526481. doi:10.1016/j.bja.2022.10.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。